3.26 (95% CI 1.38-7.70) in the adjusted model, and for “sarcopenia (EWGSOP)”; whereas for “sarcopenia (EWGSOP2)” and “sarcopenia (FNIH)”, the increased hazard ratios did not reach statistical significance (Table 4 ).
← all excerpts
Sarcopenia prevalence and associations with mortality and hospitalisation by various sarcopenia definitions in 85-89 year old community-dwelling men: a report from the ULSAM study.
1
—
—